Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

142.57
-3.1400-2.15%
Post-market: 142.53-0.0438-0.03%19:30 EDT
Volume:3.06M
Turnover:440.59M
Market Cap:272.02B
PE:21.55
High:145.50
Open:145.39
Low:142.56
Close:145.71
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.68
T/O Rate:0.17%
Dividend:4.67
Dividend Rate:3.27%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.55
PE(LYR):19.94

Loading ...

Novartis AG Falls Wednesday, Outperforms Market

Dow Jones
·
7 hours ago

Novartis AG Rises Monday, Outperforms Market

Dow Jones
·
Sep 29

Novartis AG Rises Friday, Outperforms Market

Dow Jones
·
Sep 26

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Novartis Poised for Sales Growth Acceleration

Dow Jones
·
Sep 24

Novartis AG Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 24

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

Novartis AG Rises Monday, Underperforms Market

Dow Jones
·
Sep 22

Novartis AG Falls Friday, Outperforms Market

Dow Jones
·
Sep 19

Novartis announces positive CHMP opinion for Cosentyx

TIPRANKS
·
Sep 18

Novartis Halts ALS Drug Development After Phase 2 Trial Miss

MT Newswires Live
·
Sep 17

Novartis AG Rises Wednesday

Dow Jones
·
Sep 17

Novartis to End ALS Trial Amid String of Study Failures

Dow Jones
·
Sep 16

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Sep 15

NYSE Order Imbalance 99880.0 Shares on Sell Side

THOMSON REUTERS
·
Sep 15

Novartis AG Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

Movement Alert|Novartis AG Rises 3.19% in Regular Trading, Major Shareholder Pushes for Board Overhaul as Analysts Upgrade Rating

Market Focus
·
Sep 14

Movement Alert|Novartis AG Rises 3.04% in Pre-Market Trading, Major Shareholder Pushes for Board Overhaul as Brokerages Upgrade Ratings

Market Focus
·
Sep 14

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Novartis: More Pain on the Way?

Dow Jones
·
Sep 12